Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.36 - $1.78 $22,582 - $111,657
-62,729 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.51 - $1.0 $125,369 - $245,823
-245,823 Reduced 79.67%
62,729 $41,000
Q4 2021

Feb 14, 2022

BUY
$0.91 - $4.16 $231,579 - $1.06 Million
254,483 Added 470.66%
308,552 $282,000
Q3 2021

Nov 15, 2021

BUY
$3.78 - $5.18 $59,773 - $81,911
15,813 Added 41.33%
54,069 $222,000
Q2 2021

Aug 16, 2021

SELL
$4.1 - $5.33 $722,870 - $939,732
-176,310 Reduced 82.17%
38,256 $166,000
Q1 2021

May 17, 2021

SELL
$4.93 - $7.15 $539,208 - $782,016
-109,373 Reduced 33.76%
214,566 $1.08 Million
Q4 2020

Feb 16, 2021

SELL
$4.55 - $7.29 $113,026 - $181,090
-24,841 Reduced 7.12%
323,939 $2.04 Million
Q3 2020

Nov 16, 2020

BUY
$4.22 - $6.04 $126,840 - $181,544
30,057 Added 9.43%
348,780 $1.5 Million
Q2 2020

Aug 14, 2020

BUY
$3.76 - $8.01 $418,931 - $892,458
111,418 Added 53.75%
318,723 $1.87 Million
Q1 2020

May 15, 2020

SELL
$3.5 - $8.51 $71,851 - $174,701
-20,529 Reduced 9.01%
207,305 $906,000
Q4 2019

Feb 14, 2020

BUY
$4.52 - $7.91 $564,312 - $987,547
124,848 Added 121.23%
227,834 $1.55 Million
Q3 2019

Nov 14, 2019

SELL
$4.91 - $9.31 $22,816 - $43,263
-4,647 Reduced 4.32%
102,986 $506,000
Q2 2019

Aug 14, 2019

BUY
$7.08 - $10.6 $62,091 - $92,962
8,770 Added 8.87%
107,633 $793,000
Q1 2019

May 15, 2019

BUY
$7.67 - $9.96 $315,651 - $409,893
41,154 Added 71.31%
98,863 $802,000
Q4 2018

Feb 14, 2019

SELL
$6.59 - $11.28 $910,342 - $1.56 Million
-138,140 Reduced 70.53%
57,709 $455,000
Q3 2018

Nov 14, 2018

BUY
$9.35 - $12.44 $1.83 Million - $2.44 Million
195,849 New
195,849 $2.11 Million
Q2 2018

Aug 14, 2018

SELL
$9.11 - $28.88 $164,827 - $522,525
-18,093 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$14.18 - $35.6 $256,558 - $644,110
18,093 New
18,093 $467,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0

About CATALYST BIOSCIENCES, INC.


  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.